Moderna (MRNA) Announces Phase 1/2 Data on mRNA-3927

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. SPCX
10. SPY

Go back to Moderna (MRNA) Announces Phase 1/2 Data on mRNA-3927

Moderna (MRNA) Q1 earnings, revenue surprisingly tops consensus estimates

May 4, 2023 9:50 AM EDT

Moderna (NASDAQ: MRNA) shares opened higher Thursday on the back of its surprising earnings and revenue beat.

The drugmaker had been expected to post a $1.75 loss in the quarter, however, it reported Q1 EPS of $0.19, topping expectations by $1.94. In addition, revenue... More